Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021)
Treace Medical Concepts' (TMCI) quarterly Preferred Dividend Payments came in at $39000.0 in Q2 2021, down 75.47% on a YoY basis from $159000.0 in Q2 2020, and down 75.32% quarter-over-quarter from $158000.0 in Q1 2021.
Analysis
Treace Medical Concepts (TMCI) Preferred Dividend Payments (2020 - 2021) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Preferred Dividend Payments for 2 consecutive years, with $39000.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Preferred Dividend Payments fell 75.47% year-over-year to $39000.0; the trailing twelve-month figure through Jun 2022 stood at $39000.0 (down 92.49% YoY), and the FY2021 full-year result was $196000.0, down 69.38% from the prior year.
- Preferred Dividend Payments declined to $39000.0 in Q2 2021 per TMCI's latest filing, from $158000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $161000.0 in Q3 2020 and bottomed at $39000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 39,000.00 |
| Mar 31, 2021 | 158,000.00 |
| Dec 31, 2020 | 161,000.00 |
| Sep 30, 2020 | 161,000.00 |
| Jun 30, 2020 | 159,000.00 |
| Mar 31, 2020 | 158,000.00 |